Thyrocare acquires stake in Trovera as part of Nueclear sale
Thyrocare acquires stake in Trovera as part of Nueclear sale. Thyrocare Technologies has acquired compulsorily convertible preference shares in Trovera Healthcare Private Limited. This move is part of the consideration for selling its wholly-owned subsidiary, Nueclear Healthcare Limited. The transaction reflects a strategic realignment in the diagnostics space.
📊 STOCKS: $THYROCARE | 🏢 SECTOR: Healthcare | #MEDIUMIMPACT #Acquisition
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.